CryoLife, Inc. (CRY) Q2 2020 Earnings Conference Call July 30, 2020 4:30 PM ET Company Participants Lynn Lewis – Gilmartin Group Pat Mackin – Chief Executive Officer Ashley Lee – Chief Financial Officer Conference Call Participants Cecilia Furlong – Canaccord Genuity Suraj Kalia – Oppenheimer David Saxon – Needham & Company Jeffrey Cohen – Ladenburg Thalmann Operator Greetings, and welcome to CryoLife’s Second Quarter 2020 Financial Conference Call. At this time, all participants are in a listen-only mode. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission file number: 1-13165 CRYOLIFE INC. (Exact name of registrant as specified in its charter) Florida 59-2417093 (State or oth ...

CryoLife, Inc. (CRY) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET Company Participants Lynn Lewis - Gilmartin Group Pat Mackin - CEO Ashley Lee - CFO Conference Call Participants Jason Mills - Canaccord Genuity David Saxon - Needham and Company Suraj Kalia - Oppenheimer and Company Jeffrey Cohen - Ladenburg Thalmann Operator Greetings, and welcome to the CryoLife 2020 first quarter financial conference call. [Operator instructions] As a reminder, this conference is being recorded. It is now m ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission file number: 1-13165 CRYOLIFE INC. (Exact name of registrant as specified in its charter) Florida 59-2417093 (State or ot ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13165 CRYOLIFE, INC. (Exact name of registrant as specified in its charter) Florida (State or other jurisdiction of incorporation or or ...

CryoLife, Inc. (CRY) Q4 2019 Earnings Conference Call February 13, 2020 4:30 PM ET Company Participants Lynn Lewis - Gilmartin Group Pat MacKin - Chief Executive Officer Ashley Lee - Chief Financial Officer Conference Call Participants Suraj Kalia - Oppenheimer David Saxon - Needham & Company Jeffrey Cohen - Landenburg Thalmann Brooks O'Neil - Lake Street Capital Markets Joe Munda - First Analysis Operator Greetings. Welcome to CryoLife's Fourth Quarter and Year End 2019 Financial Conference Call. [Operator ...

CryoLife, Inc. (CRY) Q3 2019 Results Conference Call October 30, 2019 5:30 PM ET Company Participants Greg Chodaczek - Investor Relations Pat MacKin - Chief Executive Officer Ashley Lee - Chief Financial Officer Conference Call Participants Cecilia Furlong - Canaccord Genuity Mike Matson - Needham & Company Jeffrey Cohen - Landenburg Thalmann Brooks O'Neil - Lake Street Capital Joe Munda - First Analyst Suraj Kalia - Oppenheimer Operator Greetings. Welcome to CryoLife's Third Quarter 2019 Financial Conferen ...

| --- | --- | --- | --- | |-------|------------|----------------|-------| | | | | | | | | | | | | | | | | | | | | | | | 59-2417093 | | | | Employer | (I.R.S. | | | | No.) | Identification | | | | 30144 | | | | | (Zip Code) | | | UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE ...

| --- | --- | --- | --- | |-------|------------|----------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | 59-2417093 | | | | | Employer | (I.R.S. | | | | No.) | Identification | | | | 30144 | | | | | (Zip Code) | | | UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) O ...

CryoLife, Inc. (CRY) Q2 2019 Earnings Conference Call July 30, 2019 4:30 PM ET Company Participants Greg Chodaczek – Investor Relations-Gilmartin Group Pat MacKin – Chief Executive Officer Ashley Lee – Chief Financial Officer Conference Call Participants David Rescott – Canaccord Genuity Mike Matson – Needham & Company Jeffrey Cohen – Ladenburg Thalmann Suraj Kalia – Northland Securities Joe Munda – First Analysis Operator Greetings, and welcome to the CryoLife’s Second Quarter 2019 Financial Results Confer ...